Year-End Report Nanologica 2020
SUMMARY OF THE PERIODFINANCIAL OVERVIEW · Net revenue increased by 75 percent to TSEK 16 135 (9 227) in total, of which the fourth quarter TSEK 6 071 (2 731) · The operating result for the period was TSEK -19 571 (-20 066), of which the fourth quarter TSEK -3 648 (-6 260) · Loss for the period was TSEK -22 199 (-21 080), of which the fourth quarter TSEK -5 427 (-6 855) · Loss per share for the period was SEK -0,93 (-1,27), of which the fourth quarter SEK -0,20 (-0,41) · Cash and cash equivalents at the end of the period amounted to TSEK 66 364 (1 176) SIGNIFICANT EVENTS